SCHEMBL5352596

SCHEMBL5352596

CCO/C(Cc1ccccc1Cl)=N\C#N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
PKM P14618 1/20 0.39
MAPT P10636 3/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
CTBP2 P56545 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPK8 P45983 1/20 0.37
MAPK9 P45984 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.36
NR4A2 P43354 2/20 0.36
SHBG P04278 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
KDM4E B2RXH2 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5352600 1.00 ALDH1A1 (0.40) ALDH1A1PKMMAPTLMNAGAA
SCHEMBL5342412 0.85 CTBP2 (0.40) ALDH1A1MAPTGAACTBP2MAPK8
SCHEMBL5342416 0.85 CTBP2 (0.40) ALDH1A1MAPTGAACTBP2MAPK8
SCHEMBL2827522 0.82 ALDH1A1 (0.40) ALDH1A1PKMLMNACYP1A2CYP2C19
SCHEMBL2827524 0.82 ALDH1A1 (0.40) ALDH1A1PKMLMNACYP1A2CYP2C19
SCHEMBL9734347 0.81 PKM (0.47) ALDH1A1PKMMAPTLMNAGAA
SCHEMBL9734349 0.81 PKM (0.47) ALDH1A1PKMMAPTLMNAGAA
SCHEMBL2828454 0.81 SMN1; SMN2 (0.36) PKMMAPTLMNAGAACYP1A2
SCHEMBL2828455 0.81 SMN1; SMN2 (0.36) PKMMAPTLMNAGAACYP1A2
SCHEMBL5344132 0.79 POLQ (0.43) ALDH1A1KDM4EMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232686-A1 Cyanoamidine P2X7 Antagonists for the Treatment of Pain CARROLL WILLIAM A 2007-10-04 US disclosed
US-7241776-B2 Cyanoamidine P2X7 antagonists for the treatment of pain ABBOTT LABORATORIES (US) 2007-07-10 US disclosed
US-20060025614-A1 Cyanoamidine P2X7 antagonists for the treatment of pain ABBVIE INC. 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025614-A1 Cyanoamidine P2X7 antagonists for the treatment of pain P2RX2, P2RX1, P2RX7 ALDH1A1 3848/4885PKM 1939/4885MAPT 2216/4885
US-20070232686-A1 Cyanoamidine P2X7 Antagonists for the Treatment of Pain P2RX2, P2RX1, P2RX7 ALDH1A1 3848/4885PKM 1939/4885MAPT 2216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.